Hardman Johnston Global Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38.6M | Sell |
|
|||||
2025
Q1 | $41.3M | Buy |
|
|||||
2024
Q4 | $34.3M | Sell |
|
|||||
2024
Q3 | $43.5M | Sell |
|
|||||
2024
Q2 | $44.3M | Sell |
|
|||||
2024
Q1 | $39.7M | Sell |
|
|||||
2023
Q4 | $42.1M | Sell |
|
|||||
2023
Q3 | $44.3M | Sell |
|
|||||
2023
Q2 | $48M | Sell |
|
|||||
2023
Q1 | $47.5M | Sell |
|
|||||
2022
Q4 | $47.2M | Sell |
|
|||||
2022
Q3 | $42.9M | Sell |
|
|||||
2022
Q2 | $52.4M | Sell |
|
|||||
2022
Q1 | $69.1M | Sell |
|
|||||
2021
Q4 | $61.8M | Sell |
|
|||||
2021
Q3 | $67.6M | Buy |
|
|||||
2021
Q2 | $66.9M | Buy |
|
|||||
2021
Q1 | $38.7M | Sell |
|
|||||
2020
Q4 | $47.2M | Sell |
|
|||||
2020
Q3 | $51.7M | Buy |
|
|||||
2020
Q2 | $48.1M | Sell |
|
|||||
2020
Q1 | $47.7M | Sell |
|
|||||
2019
Q4 | $55.9M | Sell |
|
|||||
2019
Q3 | $50M | Buy |
|
|||||
2019
Q2 | $46.3M | Sell |
|
|||||
2019
Q1 | $45.8M | Buy |
|
|||||
2018
Q4 | $42.7M | Sell |
|
|||||
2018
Q3 | $52.9M | Buy |
|
|||||
2018
Q2 | $43.2M | Sell |
|
|||||
2018
Q1 | $43.5M | Buy |
|
|||||
2017
Q4 | $35.1M | Buy |
|